Skip to content

EXOZ EXOZ Current ratio

Current ratio at other companies

Gevo logo
GevoGEVO
4.3×+2.3×
Ginkgo Bioworks logo
Ginkgo BioworksDNA
5.2×+0.3×
NAG
Niagen Bioscience, Inc. Common StockNAGE
4.6×+0.9×
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
2.5×+0.1×
Opko Health logo
Opko HealthOPK
3.6×+1.1×
Upexi logo
UpexiUPXI
1.7×+1.4×

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×

Where this comes from

Calculated from EXOZ’s reported figures.

Based on the most recent quarter.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's current ratio?
EXOZ (EXOZ) reported current ratio of 1.3× in Q1 2026.
How has EXOZ's current ratio changed year-over-year?
EXOZ's current ratio decreased by 79.7% year-over-year, from 6.5× to 1.3×.
What is the long-term trend for EXOZ's current ratio?
Over 2 years (2023 to 2025), EXOZ's current ratio has grown at a 123.7% compound annual growth rate (CAGR), from 0.5× to 2.5×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.